Articles

Protecting the heart and helping to reduce mortality, study takes closer look at beta-adrenoceptor inhibition in diabetes.

Only 3.1% Americans engage in activities to prevent a diabetes diagnosis.

It is unclear whether SGLT2i show reduction in mortality in all patients with type 2 or just in patients with type 2 diabetes with increased cardiovascular risk.

More specific classifications for the disease could lead to more personalized treatments in the future. Is it time?

Study confirms recent guideline changes on metformin use in moderate-to-severe chronic kidney disease.

Researchers complete examination of class of type 2 medication.

Very low incidence of end stage renal disease (ESRD) was found in patients with childhood-onset diabetes type 1 in Norway.

Management of obesity by dietary, pharmacologic, and surgical intervention can provide very positive results.

Study finds disease duration in middle age to be independently related to development of subclinical atherosclerosis and cardiac dysfunction later in life.

Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.